Patent details

EP1663989 Title: CRYSTALLINE FORM OF BIS (E)-7- 4-(4-FLUOROPHENYL)-6-IS OPROPYL-2- METHYL(METHYLSULFONYL)AMINO PYRIMIDIN-5-YL&r sqb;(3R,5S)-3,5-DIHYDROXYHEPT-6 -ENOICACID CALCIUM SALT

Basic Information

Publication number:
EP1663989
PCT Application Number:
PCT/GB/2004/003829
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP047683768
PCT Publication Number:
WO/2005/023779
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CRYSTALLINE FORM OF BIS (E)-7- 4-(4-FLUOROPHENYL)-6-IS OPROPYL-2- METHYL(METHYLSULFONYL)AMINO PYRIMIDIN-5-YL&r sqb;(3R,5S)-3,5-DIHYDROXYHEPT-6 -ENOICACID CALCIUM SALT
French Title of Invention:
FORME CRISTALLINE DU SEL DE CALCIUM DE BIS ACIDE (E)-7- 4-(4-FLUOROPHENYL)-6-ISOPROPYL-2- METHYL(METHYLSULFONYL)AMINO PYRIMIDIN-5-YL (3R,5S)-3,5-DIHYDROXYHEPT-6-ENOIQUE
German Title of Invention:
KRISTALLINE FORM VON BISÖ(E)-7-Ö4-(4-FLUORPHENYL)-6-ISOPROPYL-2-ÖMETHYL(METHYLSULFONYL)AMINOÜPYRIMIDIN-5-YLÜ(3R,5S)-3,5-DIHYDROXYHEPT-6-ENSÄUREÜ-CALCIUMSALZ
SPC Number:

Dates

Filing date:
08/09/2004
Grant date:
15/04/2009
EP Publication Date:
15/04/2009
PCT Publication Date:
17/03/2005
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/06/2006
EP B1 Publication Date:
15/04/2009
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
08/09/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
08/09/2004
 
 

Name:
AstraZeneca UK Limited
Address:
15 Stanhope Gate, London, Greater London W1K 1LN, United Kingdom (GB)

Agent

Name:
VAN MALDEREN MICHEL
From:
28/05/2009
Address:
ROUTE D'ARLON 261, 8002, STRASSSEN, Luxembourg (LU)
To:

Inventor

1

Name:
BOOTH Rebecca, Jane AstraZeneca Charter Way
Address:
United Kingdom (GB)

2

Name:
CRABB Jeffrey, Norman AstraZeneca Avlon Works
Address:
United Kingdom (GB)

3

Name:
JONES David, Wyn, Calvert AstraZeneca
Address:
United Kingdom (GB)

4

Name:
HORBURY John AstraZeneca Avlon Works
Address:
United Kingdom (GB)

5

Name:
CITTERN Peter, Anthony AstraZeneca Avlon Works
Address:
United Kingdom (GB)

Priority

1

Priority Number:
0321127
Priority Date:
10/09/2003
Priority Country:
United Kingdom (GB)

2

Priority Number:
0404859
Priority Date:
04/03/2004
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
C07D 239/42;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
25/08/2023
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages